SUMOylation of TEAD1 Modulates the Mechanism of Pathological Cardiac Hypertrophy

Documenti analoghi

• AJUBA Attenuates Pathological Cardiac Hypertrophy by Enhancing NEDD4‐Mediated Ubiquitination and Degradation of DVL2
  di: Liqin Zhuang, et al.
  Pubblicazione: (2026)
• Mitophagy in Hypertensive Cardiac Hypertrophy: Mechanisms and Therapeutic Implications
  di: Shijun Li, et al.
  Pubblicazione: (2025)
• Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
  di: Zhengyuan Huo, et al.
  Pubblicazione: (2024)
• TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2
  di: Risheng Zhao, et al.
  Pubblicazione: (2026)
• Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination
  di: Lingfeng Zhong, et al.
  Pubblicazione: (2025)